Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Piperidine-based drug discovery / / Ruben Vardanyan
| Piperidine-based drug discovery / / Ruben Vardanyan |
| Autore | Vardanyan Ṛuben |
| Pubbl/distr/stampa | Amsterdam, Netherlands : , : Elsevier, , 2017 |
| Descrizione fisica | 1 online resource (359 pages) : illustrations |
| Disciplina | 615.19 |
| Collana | Heterocyclic Drug Discovery Series |
| Soggetto topico |
Drugs - Design
Drug development Piperidine |
| ISBN | 0-12-813428-3 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910583485503321 |
Vardanyan Ṛuben
|
||
| Amsterdam, Netherlands : , : Elsevier, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Synthesis of essential drugs [[electronic resource] /] / Ṛ. S. Vardanyan, V. J. Hruby
| Synthesis of essential drugs [[electronic resource] /] / Ṛ. S. Vardanyan, V. J. Hruby |
| Autore | Vardanyan Ṛuben |
| Pubbl/distr/stampa | Amsterdam ; ; London, : Elsevier, 2006 |
| Descrizione fisica | 1 online resource (635 p.) |
| Disciplina |
615.19
615.7 |
| Altri autori (Persone) | HrubyVictor J. <1938-> |
| Soggetto topico |
Pharmaceutical chemistry
Drugs - Design |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-64180-0
9786610641802 0-08-046212-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
front cover; copyright; front matter; Preface; table of contents; body; General Anesthetics; Inhalation Anesthetics; Noninhalation Anesthetics; Local Anesthetics; Local Anesthetics of the Aminoether Series; Local Anesthetics of the Aminoamide Series; Topical Anesthetics; Analgesics; Opioid Analgesics; Agonists; Mixed agonists/antagonists; Opioid antagonists; Nonsteroid Anti-Inflammatory Drugs and Anti-Fever Analgesics; Salicylic acid derivatives; Pyrazolonees; p-Aminophenol derivatives; Anthranylic acid derivatives; Propionic acid derivatives; Acetic acid derivatives
Indolyl/indeneacetic acidsOxicames; Soporific Agents (Hypnotics and Sedative Drugs); Barbiturates; Long-acting barbiturates; Intermediate-acting barbiturates; Short-action barbiturates; Ultrashort-action barbiturates; Benzodiazepines; Other Hypnotics and Sedative Drugs; Anxiolytics (Tranquilizers); Benzodiazepines; Anxiolytic of Nonbenzodiazepine Structures; Antipsychotics (Neuroleptics); Phenothiazine Derivatives; Thioxanthene Derivatives; Butyrophenone Derivatives; Dihydroindolone Derivatives; Dibenzoxazepine and Dibenzdiazepine Derivatives; Diphenylbutylpiperidine Derivatives Other NeurolepticsLithium Derivatives; Antidepressants; Tricyclic Antidepressants; Tertiary amines-representatives of tricyclic antidepressants; Secondary amines-representatives of tricyclic antidepressants; Monoaminooxidase Inhibitors; Second-Generation Antidepressants (Atypical Antidepressants); Amphetamines and Other CNS Stimulators; Central Nervous System Stimulants; Psychomotor Stimulants; Methylxanthines; Amphetamines, methylphenidate, and pemoline; Respiratory Stimulants or Analeptics; Appetite Suppressants or Anorectics; Antiepileptic Drugs; Hydantoin Derivatives; Barbiturates SuccinimidesValproic Acid; Carbamazepine; Benzodiazepines; Acetazolamide; Oxazolidines; Antiparkinsonian Drugs; Drugs Affecting the Dopaminergic Systems of the Brain; Anticholinergic Drugs (Central Cholinoblockers); Adrenergic (Sympathomimetic) Drugs; Direct-Acting Agonists; Drugs stimulating α- and β-adrenoreceptors; Drugs stimulating predominantly β-adrenoreceptors; Drugs stimulating predominantly α-adrenoreceptors; Antiedema sympathomimetics; Indirect-Acting Agonists; Agonists of Mixed Action; Adrenoblocking Drugs; β-Adrenoblockers; α-Adrenoblockers; Long-lasting noncompetitive antagonists Nonselective, reversible competitive adrenoblockersReversible, competitive α1-selective adrenoblockers; Ergot alkaloids (alkaloids of ergot); Selective α2-adrenoblockers; Adrenergic Neuron Blockers; Cholinomimetics; Direct-Acting Cholinomimetics; Choline esters; Natural muscarinic alkaloids; Natural nicotinic alkaloids; Indirect-Acting Cholinomimetics; Reversible cholinesterase inhibitors; Carbamates; Quaternary amines; Irreversible cholinesterase inhibitors; Other organophosphorous cholinesterase inhibitors; Anticholinergic Drugs; Antimuscarinic Drugs; Alkaloids Anticholinergics of the quaternary amine series |
| Record Nr. | UNINA-9910511752303321 |
|
Vardanyan Ṛuben
|
||
| Amsterdam ; ; London, : Elsevier, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Synthesis of essential drugs / / Ṛ. S. Vardanyan, V. J. Hruby
| Synthesis of essential drugs / / Ṛ. S. Vardanyan, V. J. Hruby |
| Autore | Vardanyan Ṛuben |
| Pubbl/distr/stampa | Amsterdam ; ; London : , : Elsevier, , 2006 |
| Descrizione fisica | 1 online resource (xvi, 617 pages) : illustrations |
| Disciplina |
615.19
615.7 |
| Altri autori (Persone) | HrubyVictor J. <1938-> |
| Soggetto topico |
Pharmaceutical chemistry
Drugs - Design |
| ISBN |
1-280-64180-0
9786610641802 0-08-046212-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
front cover; copyright; front matter; Preface; table of contents; body; General Anesthetics; Inhalation Anesthetics; Noninhalation Anesthetics; Local Anesthetics; Local Anesthetics of the Aminoether Series; Local Anesthetics of the Aminoamide Series; Topical Anesthetics; Analgesics; Opioid Analgesics; Agonists; Mixed agonists/antagonists; Opioid antagonists; Nonsteroid Anti-Inflammatory Drugs and Anti-Fever Analgesics; Salicylic acid derivatives; Pyrazolonees; p-Aminophenol derivatives; Anthranylic acid derivatives; Propionic acid derivatives; Acetic acid derivatives
Indolyl/indeneacetic acids; Oxicames; Soporific Agents (Hypnotics and Sedative Drugs); Barbiturates; Long-acting barbiturates; Intermediate-acting barbiturates; Short-action barbiturates; Ultrashort-action barbiturates; Benzodiazepines; Other Hypnotics and Sedative Drugs; Anxiolytics (Tranquilizers); Benzodiazepines; Anxiolytic of Nonbenzodiazepine Structures; Antipsychotics (Neuroleptics); Phenothiazine Derivatives; Thioxanthene Derivatives; Butyrophenone Derivatives; Dihydroindolone Derivatives; Dibenzoxazepine and Dibenzdiazepine Derivatives; Diphenylbutylpiperidine Derivatives Other Neuroleptics; Lithium Derivatives; Antidepressants; Tricyclic Antidepressants; Tertiary amines-representatives of tricyclic antidepressants; Secondary amines-representatives of tricyclic antidepressants; Monoaminooxidase Inhibitors; Second-Generation Antidepressants (Atypical Antidepressants); Amphetamines and Other CNS Stimulators; Central Nervous System Stimulants; Psychomotor Stimulants; Methylxanthines; Amphetamines, methylphenidate, and pemoline; Respiratory Stimulants or Analeptics; Appetite Suppressants or Anorectics; Antiepileptic Drugs; Hydantoin Derivatives; Barbiturates Succinimides; Valproic Acid; Carbamazepine; Benzodiazepines; Acetazolamide; Oxazolidines; Antiparkinsonian Drugs; Drugs Affecting the Dopaminergic Systems of the Brain; Anticholinergic Drugs (Central Cholinoblockers); Adrenergic (Sympathomimetic) Drugs; Direct-Acting Agonists; Drugs stimulating α- and β-adrenoreceptors; Drugs stimulating predominantly β-adrenoreceptors; Drugs stimulating predominantly α-adrenoreceptors; Antiedema sympathomimetics; Indirect-Acting Agonists; Agonists of Mixed Action; Adrenoblocking Drugs; β-Adrenoblockers; α-Adrenoblockers; Long-lasting noncompetitive antagonists Nonselective, reversible competitive adrenoblockers; Reversible, competitive α1-selective adrenoblockers; Ergot alkaloids (alkaloids of ergot); Selective α2-adrenoblockers; Adrenergic Neuron Blockers; Cholinomimetics; Direct-Acting Cholinomimetics; Choline esters; Natural muscarinic alkaloids; Natural nicotinic alkaloids; Indirect-Acting Cholinomimetics; Reversible cholinesterase inhibitors; Carbamates; Quaternary amines; Irreversible cholinesterase inhibitors; Other organophosphorous cholinesterase inhibitors; Anticholinergic Drugs; Antimuscarinic Drugs; Alkaloids; Anticholinergics of the quaternary amine series |
| Record Nr. | UNINA-9910784598403321 |
|
Vardanyan Ṛuben
|
||
| Amsterdam ; ; London : , : Elsevier, , 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||